Stacey Johnson
Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.
Posts by: Stacey
Right Turn: Please read this blog
You know how you’ve made a resolution for 2019 that will make you a better, happier person? Well did you know last Friday (January 12) was the day when most people give up on their resolutions, according to the Independent, reporting on a new study? Signals isn’t a person, so it doesn’t get caught […]
Right Turn: A top 10 list for 2018 blogs
It’s the time of year when media either look forward, with predictions, or backwards to highlight what resonated with readers. (In 2016, I provided a list of my top five favourite posts, not yours, in case you’d like to check it out.) Since you are a quiet bunch in terms of leaving comments, this list […]
Right Turn: Changing people’s lives, one stem cell “Christmas tree” at a time
I’m on vacation and hope you are too! But catching up on one’s sleep and spending time with family is no excuse for putting learning on hold. If you like “sciart,” then these award-winning images should enhance your festive mood. Catarina Moura, University of Southampton, produced these laser-based stem cell beauties. You can read the […]



Right Turn: Are we facing a COGs crisis? Some moments from Phacilitate 2019
There is no denying that the joining of Phacilitate Leaders World and World Stem Cell Summit has resulted in a grand buffet of tasty treats to appeal to an assortment of consumers. For the second year, the two conferences have attracted academics, industry, government, bioethicists, regulators and philanthropists to Miami, Florida, for talks, partnering, networking, […]